From January 12, 2024 to January 15, 2024, the company has repurchased 160,000 shares, representing 0.93% for ¥303.36 million. With this, the company has completed the repurchase of 160,000 shares, representing 0.93% for ¥303.36 million under the buyback announced on January 12, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,464 JPY | +1.11% | -2.38% | +29.34% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.34% | 245M | |
+21.28% | 44.4B | |
+24.41% | 23.03B | |
+19.22% | 15.14B | |
+12.87% | 13.12B | |
+44.67% | 11.85B | |
-9.68% | 6.99B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.07% | 5.52B |
- Stock Market
- Equities
- 4577 Stock
- News Daito Pharmaceutical Co.,Ltd.
- Tranche Update on Daito Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on January 12, 2024.